They have delivered everything they said they would, there has only been one surprise IMO, how effective their compound is at reducing cholesterol. Typical biotech sell off, takes time to register for trials, get patients etc etc, and covid doesn't help with getting patients. But, there have been no delays I dont believe, happy to be corrected. This is biotech life, a few shots of news and SP action, then nothing for ages and the stock sells off. I agree we have all bought the dip (i just wish I didnt top up at 35c on the first good run). Long term I'm confident ill get multiples of that price.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
-0.025(9.62%) |
Mkt cap ! $49.56M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 26.0¢ | 23.0¢ | $152.5K | 645.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 141100 | 2 |
View Market Depth
| Last trade - 15.59pm 19/06/2025 (20 minute delay) ? |
| NYR (ASX) Chart |